Evidence map›Paper›PMID 36442541›Full record

ArticleMolecular and cellular neurosciences2023

Regulation of PP1 interaction with I-2, neurabin, and F-actin.

Karl Foley, Nancy Ward, Hailong Hou, Abigail Mayer, Cody McKee, Houhui Xia

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular neurosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Karl FoleyDepartment of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Neuroscience, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA.
Nancy WardDepartment of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA.
Hailong HouDepartment of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA.
Abigail MayerDepartment of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Neuroscience, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA.
Cody McKeeDepartment of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Neuroscience, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA.
Houhui XiaDepartment of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA; Department of Neuroscience, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY 14642, USA. Electronic address: houhui_xia@urmc.rochester.edu.
University of Rochester Medical Center · US

Funding

Inhibitor-2 is a positive regulator for PP1's synaptic and cognitive functionsR01MH109719 · NIMH · UNIVERSITY OF ROCHESTER · PI XIA, HOUHUI · 2016 to 2020
$1.9M
Protein phosphatase 1 isoforms and human de novo mutations in synaptic plasticityF30MH122046 · NIMH · UNIVERSITY OF ROCHESTER · PI FOLEY, KARL FRANCIS WILSON · 2020 to 2023
$205k
NIMH NIH HHS F30 MH122046NIMH NIH HHS R01 MH109719
6 · The paper itself

Abstract

Reversible phosphorylation is a fundamental regulatory mechanism required for many biological processes and is coordinated by the opposing actions of protein kinases and phosphatases. Protein phosphatase 1 (PP1) is a major protein phosphatase that plays an important role in many fundamental physiological processes including synaptic transmission and memory formation. Here we investigate the regulation of PP1 by prominent signaling proteins and synaptic scaffolds including GSK3β, inhibitor-2 (I-2), neurabin (Nrb), and actin. While GSK3β is known to regulate PP1 via phosphorylation of the PP1-binding protein I-2, we found that GSK3β directly regulates PP1 via inhibitory phosphorylation in neurons. Additionally, using bioluminescence resonance energy transfer (BRET), we found that GSK3β alters PP1-I-2 interaction in living cells. The effect of GSK3β on PP1-I-2 interaction is independent of the PP1 C-terminal tail, contrary to predictions based on previous findings from purified proteins. I-2 has been shown to form a trimeric complex with PP1 and Nrb, a major synaptic scaffold for promoting PP1 localization to the actin cytoskeleton. Utilizing BRET, we found that Nrb promotes PP1-actin interaction, however no BRET was detected between I-2 and F-actin. Finally, we found that stabilizing F-actin promotes Nrb-PP1 binding and may also lead to conformational changes between Nrb-I-2 and Nrb-F-actin complexes. Overall, our findings elaborate the dynamic regulation of PP1 complexes by GSK3β, targeting proteins, and actin polymerization.

Indexed as

Actin CytoskeletonActinsGlycogen Synthase Kinase 3 betaNeurabinsPhosphorylationProtein Phosphatase 1ActinsGlycogen Synthase Kinase 3 betaNeurabinsProtein Phosphatase 1BRETF-actinGSK3βInhibitor-2NeurabinProtein phosphatase 1

Identifiers

PMID36442541
PMCPMC10038014
OpenAlexW4309947232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.